GSK "BIRYULEVO-VOSTOCHNOE", Moscow

Economic indicators

Net loss (RA) of GSK BIRYULEVO-VOSTOCHNOE made up 323.00 thousand RUB over 2023 compared to net profit of 289.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period by 5.80% to 1.69 million RUB from 1.79 million RUB in 2022.

Net profit (RAS) of GSK BIRYULEVO-VOSTOCHNOE grew over 2022 3.85 times to 289.00 thousand RUB from 75.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period by 12.97% to 1.79 million RUB from 1.59 million RUB over 2021.

Net profit (RAS) of GSK BIRYULEVO-VOSTOCHNOE made up 75.00 thousand RUB over 2021 compared to net loss of 87.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 22.15% to 1.59 million RUB from 1.30 million RUB over 2020.

Net loss (RA) of GSK BIRYULEVO-VOSTOCHNOE made up 87.00 thousand RUB over 2020 compared to net profit of 68.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period by 42.58% to 1.30 million RUB from 2.26 million RUB in 2019.

Net loss (RAS) of GSK BIRYULEVO-VOSTOCHNOE dropped over 2017 2.77 times to 30.00 thousand RUB from 83.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 18.25% to 1.80 million RUB from 1.52 million RUB over 2016; cost of goods sold grew by 17.35% to 1.74 million RUB from 1.48 million RUB; sales profit went up 1.54 times to 57.00 thousand RUB from 37.00 thousand RUB.

Companies in the region

• TTS-AVTO
• YUTERNA
• RADIOAVIONIKA-M
• ANO INFORMATSIONNO-PRAVOVOY TSENTR ESFIR'
• TD NIIZHB- TREYDING